Folate receptor 1 antibodies and immunoconjugates and uses thereof

NZ820689BActive Publication Date: 2026-09-29IMMUNOGEN INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: NZ820689
Authority / Receiving Office: NZ · NZ
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2010-11-12
Filing Date: 2011-02-24
Publication Date: 2026-09-29
Estimated Expiration: 2031-02-24

Application Information

Patent Timeline

12 Nov 2010

Priority

24 Feb 2011

Application

NZ820689

29 Sep 2026

Publication

NZ820689B

Inventors: AB, OLGA; GOLDMAKHER, VIKTOR S

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure 00000101_0000
Figure 00000102_0000
Figure 00000102_0001

Patent Text Reader

Abstract

Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to human folate receptor 1 are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.

Need to check novelty before this filing date? Find Prior Art